SYNOVUS FINANCIAL CORP - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 191 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
SYNOVUS FINANCIAL CORP ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$3,000
+50.0%
2330.0%0.00%
Q1 2020$2,000
+100.0%
2330.0%0.00%
Q4 2019$1,0000.0%2330.0%0.00%
Q3 2019$1,0000.0%2330.0%0.00%
Q2 2019$1,000
-50.0%
2330.0%0.00%
Q1 2019$2,000
+100.0%
2330.0%0.00%
Q4 2018$1,000
-50.0%
2330.0%0.00%
Q3 2018$2,0002330.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$3,340,0005.66%
Orchard Capital Management, LLC 1,762,731$1,265,0000.36%
Ikarian Capital, LLC 1,200,000$860,0000.11%
Ikarian Capital, LLC 800,000$575,0000.08%
XTX Topco Ltd 102,392$74,0000.03%
Nantahala Capital Management 965,800$693,0000.03%
Worth Venture Partners, LLC 63,500$46,0000.02%
Ardent Capital Management, Inc. 43,429$31,0000.02%
Virtus ETF Advisers LLC 65,149$47,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 513,292$368,0000.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders